Literature DB >> 1729393

Cytokine regulation of neuronal survival.

D E Brenneman1, M Schultzberg, T Bartfai, I Gozes.   

Abstract

Interleukin-1 is a cytokine involved in the immune response to infection and inflammation as well as a growth promotor for several cell types. Interleukin-1-like immunoreactive material has been found in the nervous system. We now show that antisera, which blocked the T-cell proliferative effects of interleukin-1 alpha, decreased neuronal cell counts (to 40% of control) in dissociated spinal cord cultures derived from fetal mice. This neuronal loss was prevented by addition of interleukin-1 alpha, and to a lesser extent by interleukin-1 beta. Exogenous interleukin-1 alpha increased the survival of neurons when added to cultures in which the electrical activity was blocked with tetrodotoxin, whereas no such cytokine-related increase in neuronal survival was observed in electrically active cultures. The antiserum-induced death could also be prevented by cotreatment of the cultures with 0.1 nM vasoactive intestinal peptide, a substance that induces the secretion of neuronal trophic factors from nonneuronal spinal cord cells and thereby increases neuronal survival in electrically inactive cultures. These studies indicate that the cytokine interleukin-1, or an immunologically cross-reactive protein, can increase neuronal survival.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729393     DOI: 10.1111/j.1471-4159.1992.tb09743.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  29 in total

Review 1.  The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.

Authors:  W S Griffin; J A Nicoll; L M Grimaldi; J G Sheng; R E Mrak
Journal:  Exp Gerontol       Date:  2000-07       Impact factor: 4.032

2.  Expression and localization of p80 interleukin-1 receptor protein in the rat spinal cord.

Authors:  Xiao-Fei Wang; Lan Yin; Jian-Guo Hu; Li-Dong Huang; Pan-Pan Yu; Xiao-Yan Jiang; Xiao-Ming Xu; Pei-Hua Lu
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke.

Authors:  Frances Rena Bahjat; Rebecca L Williams-Karnesky; Steven G Kohama; G Alexander West; Kristian P Doyle; Maxwell D Spector; Theodore R Hobbs; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-02       Impact factor: 6.200

4.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

5.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 6.  Neural-immune interactions in health and disease.

Authors:  E M Sternberg
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 7.  A VIP hybrid antagonist: from developmental neurobiology to clinical applications.

Authors:  I Gozes; M Fridkin; D E Brenneman
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

8.  Effects of Leucocytes in Acute Cerebral Disorders. Proceedings of the 1st International Symposium on this topic. Munich, Federal Republic of Germany, September 26-27, 1994.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  The use of sodium sulphide-fixed brain tissue for immunocytochemical staining of activated microglia and reactive astrocytes.

Authors:  J Mitchell; N Best; L E Sundstrom; H V Wheal
Journal:  Histochemistry       Date:  1993-01

10.  Astrocytic glucose-6-phosphatase and the permeability of brain microsomes to glucose 6-phosphate.

Authors:  R J Forsyth; K Bartlett; A Burchell; H M Scott; J A Eyre
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.